Skip to main content
Clinical Trials/ISRCTN51768118
ISRCTN51768118
Completed
Not Applicable

To evaluate whether intravenous Adenosine would replace the need for inhaled nitric oxide (iNO) in the management of Persistent Pulmonary Hypertension of the Newborn (PPHN)

Record Provided by the NHSTCT Register - 2004 Update - Department of Health (UK)0 sites9 target enrollmentSeptember 30, 2004

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
eonatal Diseases: Persistant pulmonary hypertension
Sponsor
Record Provided by the NHSTCT Register - 2004 Update - Department of Health (UK)
Enrollment
9
Status
Completed
Last Updated
11 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
September 30, 2004
End Date
TBD
Last Updated
11 years ago
Study Type
Interventional

Investigators

Sponsor
Record Provided by the NHSTCT Register - 2004 Update - Department of Health (UK)

Eligibility Criteria

Inclusion Criteria

  • Neonates with PPHN requiring mechanical ventilation and inhaled nitric oxide at 20 parts per million

Exclusion Criteria

  • Does not meet inclusion criteria

Outcomes

Primary Outcomes

Not specified

Similar Trials